Introduction
Blood vessels in the brain are organized with surprising precision, supporting the major brain circuits tasked with sensation, memory, and motion (Andreone et al., 2015; Blinder et al., 2013; Zlokovic, 2011) . Proper structural and functional brain connectivity, synaptic activity, and information processing all require precise regulation of cerebral blood flow (CBF), oxygen delivery, and energy metabolite supply (Attwell et al., 2010; Iadecola, 2013) . These key central nervous system (CNS) functions are maintained by the highly coordinated activity of multiple cell types within the neurovascular unit (NVU), including vascular cells (endothelial cells, pericytes, smooth muscle cells), glia (astrocytes, oligodendroglia, microglia) , and neurons ( Figure 1 ) (Zlokovic, 2011) .
Within the NVU, the endothelial cells form the blood-brain barrier (BBB) that limits entry of potentially neurotoxic plasma components, blood cells, and pathogens into the brain (Winkler et al., 2011) . Importantly, these endothelial cells express multiple substrate-specific transport systems that control transport of nutrients, energy metabolites, and other essential molecules from blood into the brain and the transport of metabolic waste products from the brain's interstitial fluid (ISF) into the blood. The meningeal lymphatic vessels contain cerebrospinal fluid (CSF) and immune cells and drain into the deep cervical lymph nodes (Aspelund et al., 2015; Louveau et al., 2015) . Thus, the BBB serves as a key homeostatic site of the nervous system, connecting CNS, systemic circulation, and major systems in the body such as respiratory, renal, hepatic, and immune systems.
In this Perspective, first we examine the cellular and molecular mechanisms regulating the formation and maintenance of the BBB. We then look into how major NVU cell types contribute to BBB functions and how molecular alterations and aberrant signal transduction within the NVU leads to BBB breakdown that is associated with secondary neuronal injury and neurodegeneration. In particular, we discuss the role of NVU and BBB breakdown in the etiology and pathogenesis of inherited monogenic neurological disorders and complex neurodegenerative disorders such as Alzheimer's disease (AD). Finally, we discuss key questions in the field for future investigation.
BBB Development
Different stages of BBB formation are illustrated in Figure 2A . The neural microenvironment provides initial cues for CNS angiogenesis and induction of the BBB properties (Obermeier et al., 2013) . At embryonic day E10 in mice, the angioblasts of the perineural vascular plexus penetrate the neuroectoderm guided by neuroectoderm-secreted vascular endothelial growth factor (VEGF), which results in formation of the nascent ''leaky'' blood vessels (Potente et al., 2011) . Wnt ligands secreted by neural cells elicit canonical Wnt signaling in the endothelium by binding to the Frizzled receptors (Wang et al., 2012b) and the co-receptors low-density lipoprotein receptor-related protein (LRP) 5 and 6, which in turn activates b-catenin-dependent pathways (Daneman et al., 2009; Liebner et al., 2008; ( Figure 2B ). Activation of Wnt/b-catenin signaling leads to induction of genes critical for the BBB formation, such as glucose transporter Glut1 (Stenman et al., 2008) and death receptors DR6 and TROY (Tam et al., 2012) . In addition, an orphan G-protein-coupled receptor, Gpr124, acts as a specific co-activator of Wnt/b-catenin signaling at the BBB (Kuhnert et al., 2010; .
The primitive BBB is formed at embryonic day E15 in mice (Ben-Zvi et al., 2014; Daneman et al., 2010) , but the exact timing is species dependent and varies regionally. It is debatable, whether humans and/or other mammals are born with a fully functional BBB (Saunders et al., 2013) . Recruitment of pericytes to the developing endothelial capillary wall is critical for the formation and maintenance of the BBB (Armulik et al., 2010; Bell et al., 2010; Daneman et al., 2010) . While some pathways have been implicated, it remains unclear exactly which signals are involved in the pericyte-mediated induction and regulation of the BBB ( Figure 2B) . Astrocytes recruited at a later stage further assist endothelium in acquiring BBB characteristics, barrier properties, and CNS immune quiescence (Alvarez et al., 2011) ( Figure 2B ).
The BBB functions continue to mature after birth, but the exact time window remains elusive and is likely species dependent (Hagan and Ben-Zvi, 2015; Saunders et al., 2013) . At a mature stage, the mammalian BBB is stabilized by highly specialized perivascular structures ( Figure 2C ).
Cellular Components of the BBB Endothelial Cells and Cellular Junctions
A number of factors contribute to the physical barrier of BBB, including endothelial tight junction (TJ) and adherens junction (AJ) proteins, inhibition of non-selective fenestrae, pinocytosis, and bulk-flow transcytosis, as well as suppression of leukocyte adhesion molecules (Obermeier et al., 2013) . Endothelium allows rapid free diffusion of oxygen from blood to brain and carbon dioxide from brain to blood, which is essential for normal brain metabolism and regulation of pH in the brain ISF, neurons, and other NVU cells. Small lipophilic molecules and drugs, with a molecular weight of <400 Da and form of <8 hydrogen bonds, can cross the BBB (Pardridge, 2015) .
The major endothelial transport systems and cellular junction molecules are briefly discussed below and are described in detail elsewhere (Daneman and Prat, 2015; Hagan and BenZvi, 2015; Tietz and Engelhardt, 2015; Zlokovic, 2008 Zlokovic, , 2011 . A preliminary molecular atlas of the BBB based on manual collection of available data on protein and RNA expression, as well as physiological measurements from different published investigations, is provided in Table 1 . It is noteworthy that some of the listed components are not confirmed in recent RNAseq data (see, e.g., http://web.stanford.edu/group/barres_lab/ brain_rnaseq.html). Since expression may be species, strain, disease, or context dependent, we provide Table 1 as an all-inclusive data source and encourage the readers to explore and critically examine the specifics in existing literature.
Active Efflux. Multiple ATP-binding cassette (ABC) proteins are expressed on the luminal, blood-facing endothelial plasma Pial arteries give rise to the penetrating arteries that branch into arterioles all covered by vascular smooth muscle cells (blue). The penetrating arteries are separated from brain parenchyma by the glia limitans, an astrocytic endfeet layer that forms the outer wall of the VirchowRobin spaces containing brain interstitial fluid (ISF). Arterioles branch off into capillaries, and the vessels enlarge as they become venules and veins. Brain capillary unit. Endothelial cells (red) connected by tight junctions form the blood-brain barrier. Pericytes (purple) and endothelium share a common basement membrane (yellow) and connect with each other with several transmembrane junctional proteins, including N-cadherin and connexins. Astrocytes (green) connect with pericytes, endothelial cells, and neurons (peach). Microglia (brown) regulate immune responses. Oligodendrocytes (aqua) support neurons with axonal myelin sheath. Integrins make connections between cellular and matrix components. membrane of the BBB, which restricts the permeability of a large number of toxins, including therapeutic agents (Miller, 2015) . ABC transporters are ATP-driven efflux pumps for xenobiotics and endogenous metabolites. Their high expression at the BBB contributes to CNS pharmacoresistance (Table 1) . Decreased expression and/or functional activity of ABC BBB transporters were reported in patients with Alzheimer's disease (AD) and Parkinson's disease (PD) (Zlokovic, 2011) and were shown to lead to accumulation of amyloid b-peptide (Ab) in the brain in an animal model of AD (Cirrito et al., 2005) . The clinical potential of targeting ABC transporters for disease management and drug delivery improvement, however, remains elusive.
Carrier-Mediated Transport (CMT). CMT systems are expressed by genes within the solute carrier (SLC) transporter gene family, including >300 transporter genes encoding membrane-bound proteins that facilitate the transport of a wide array of substrates across biological membranes (Lin et al., 2015) . At the BBB, the SLC proteins facilitate the trans-cellular transport of a variety of molecules, including carbohydrates, amino acids, monocarboxylic acids, hormones, fatty acids, nucleotides, organic anions, amines, choline, and vitamins (Table 1) (Daneman and Prat, 2015; Pardridge, 2015; Zlokovic, 2008) . Human genetic studies have provided important insight into the roles of the more recently characterized SLC transporters in both rare and common diseases. As discussed below, genetic alterations in brain endothelial SLC2A1 (Glut1) that transports glucose into the brain and maintains the BBB integrity and in SLC16A2 that transports T3 thyroid hormone into the brain have been implicated in the development of neurological disorders (Benarroch, 2014; Kersseboom et al., 2013) . Screening for BBB-penetrating small molecules that can use the existing CMT systems at the BBB as surrogate ligands has been recently proposed as a new model for CNS discovery programs (Pardridge, 2015) .
Receptor-Mediated Transport (RMT). Peptide bonds prevent larger peptides and proteins from using the amino acid CMT systems to cross the BBB (Zlokovic et al., 1985) . However, certain neuroactive peptides (Zlokovic, 1995) , regulatory proteins, hormones, and growth factors can use RMT systems to slowly cross the BBB (Pardridge, 2015; Zlokovic, 2008) (Table  1) . For example, Ab can cross the BBB to enter the circulation through LRP1 (Deane et al., 2004) or the other way around via the receptor for advanced glycation end products (RAGE) on RAGE-expressing endothelium, particularly under pathological conditions (Deane et al., 2003 . Moreover, RMT systems-for example, the transferrin receptor (TfR)-have been utilized for the CNS drug delivery (Bray, 2015) .
Major Facilitator Superfamily. Docosahexaenoic acid (DHA), an essential omega-3 fatty acid, is transported into the brain by the endothelial major facilitator superfamily domain-containing Restriction of paracellular and transcellular transport of solutes is accomplished by elimination of endothelial fenestrae and pinocytosis, formation of a continuous endothelial monolayer connected with the tight junctions, creation of highly selective endothelial transport systems, and establishment of specialized perivascular structures, including the basement membrane and the coverage of the endothelial capillary wall by pericytes and astrocytic endfeet. E, embryonic days; P, postnatal days. (B) Induction and differentiation. Wnt ligands (Wnt7a/7b) secreted by neural cells bind to endothelial Frizzled receptors (FZD) and the co-receptors low-density lipoprotein receptor-related protein (LRP) 5 and 6, which activate b-catenin signaling, leading to the induction of BBB specific genes. G protein coupled receptor 124 (Gpr124) co-activates Wnt/b-catenin signaling. Endothelial cells secrete platelet-derived growth factor BB (PDGF-BB), which interacts with platelet derived growth factor receptor-b (PDGFR-b) in pericytes, inducing pericyte recruitment. Pericytes and astrocytes secrete angiopoietin-1 (Ang-1) that acts on endothelial Tie-2 receptor leading to microvascular maturation and highly stable and impermeable BBB. Pericytes are required for the expression of endothelial major facilitator superfamily domain-containing protein 2a (MFSD2a) that is critical for the BBB formation and maintenance. Astrocytes secrete sonic hedgehog (SHH) that acts on endothelial patched homolog 1 (PTC-1) receptor eliciting signaling which contributes to the BBB formation. Endothelial cells secrete vascular growth factor (VEGF) and insulin growth factor (IGF-1) contributing to proper neurovascular patterning. Additional signal transduction pathways may also participate in BBB formation. TJ, tight junction. (C) Maturation and maintenance. Postnatally, brain capillaries are covered by mature pericytes sharing the basement membrane with endothelium. Astrocytic endfeet form the outer layer of the mature capillaries. Pericytes and astrocytes continue secreting matrix proteins (yellow) of the basement membrane. Signaling pathways mediating BBB induction and differentiation likely continue to play a role in BBB maturation and maintenance and their dysregulation may lead to BBB breakdown causing different central nervous system pathologies. AQP4, aquaporin-4 water channel. protein 2a (MFSD2a) (Nguyen et al., 2014) . Mice lacking Mfsd2a show brain DHA deficits and develop BBB breakdown (Ben-Zvi et al., 2014) , suggesting that MFSD2a has the dual function of transporting fatty acids into the brain and maintaining BBB integrity (Betsholtz, 2014; Zhao and Zlokovic, 2014) . TJ proteins seal brain endothelia, contributing to the anatomical barrier (Table 1) . Mutations in and loss of some TJ proteins lead to BBB breakdown and are associated with neurological disorders, as discussed below (Tietz and Engelhardt, 2015; Zlokovic, 2008) . TJ proteins are connected to cortical actin cytoskeleton via multi-domain scaffolding proteins of the peripheral membrane-associated guanylate kinase (MAGUK) family, i.e., ZO-1, ZO-2, and ZO-3 (Tietz and Engelhardt, 2015) . ZO-1 deficiency disrupts TJs, and reduced ZO-1 levels are associated with BBB breakdown in many neurological disorders (Zlokovic, 2011) (Figure 3 ). AJ proteins such as cadherins and platelet endothelial cell adhesion molecule-1 also contribute to barrier properties, and the space between these proteins is 20 nm, which is wider compared to that between TJs (Tietz and Engelhardt, 2015) (Table 1; Figure 3 ). Brain endothelial cells are anchored to the basement membrane through integrins, which interact with extracellular matrix (ECM) proteins, such as laminin, collagen, and perlecan, and mediate signaling by activating ECM ligands, growth factors, and growth factor receptors (Baeten and Akassoglou, 2011) . Mice lacking b1-integrins in endothelial cells develop aberrant cadherin signaling, loss of junctional claudin-5, and immature BBB (Yamamoto et al., 2015) . Similarly, mice lacking astrocyte-secreted laminin exhibit BBB breakdown (Yao et al., 2014) . Pericytes Pericytes share a basement membrane with endothelial cells and form direct synaptic-like peg-socket focal contacts with endothelium through N-cadherin and connexins, allowing exchanges of ions, metabolites, second messengers, and ribonucleic acids between the two cell types (Armulik et al., 2011) . Pericytes play important roles in maintaining BBB integrity, aiding in angiogenesis and microvascular stability (Armulik et al., 2011; Winkler et al., 2011) , regulating capillary diameter and CBF (Hall et al., 2014; Peppiatt et al., 2006) , and phagocytosing toxic metabolites . They have also been reported to have multipotent stem cell capabilities (Nakagomi et al., 2015) . Pericyte degeneration and injury occur in many neurological diseases, including AD (Baloyannis and Baloyannis, 2012; Farkas and Luiten, 2001; Halliday et al., 2015; Sengillo et al., 2013) , mild dementia (Montagne et al., 2015) , amyotrophic lateral sclerosis (ALS) , and stroke (Hall et al., 2014) . Much of the insight into pericyte biology stems from the analysis of pericyte-deficient mice with disrupted platelet-derived growth factor BB (PDGF-BB)/platelet-derived growth factor receptor b (PDGFR-b) signaling (Armulik et al., 2011) . PDGF-BB secreted by endothelial cells binds to heparan sulfate porteoglycans in the basement membrane, and its concentration gradient regulates pericyte proliferation, migration, and recruitment to the vessel wall through PDGFRb receptor in pericytes. PDGF-B or PDGFRb null mice have a complete loss of pericytes, resulting in rupture of CNS microvessels, microaneurysms, and embryonic lethality (Lindahl et al., 1997; Tallquist et al., 2003) . Pericytes are essential for maintaining BBB integrity in the adult and aging CNS (Armulik et al., 2010; Bell et al., 2010; Daneman et al., 2010) (Figure 3) . Implications of disrupted PDGF-B/PDFGRb signaling for human neurological disorders are discussed below. Multiple signaling pathways in pericytes contribute to CNS vascular stability, as examined in detail elsewhere (Armulik et al., 2011; Winkler et al., 2011) . Moreover, signaling between astrocytes and pericytes exerts significant impact on BBB integrity. On one hand, studies in transgenic apolipoprotein E (APOE) mice have shown that APOE4, a major genetic risk factor for AD (Zlokovic, 2013) , leads to disruption of BBB integrity by activating the proinflammatory cyclophilin-A (CypA) nuclear factor kB matrix metalloproteinase 9 (MMP-9) pathway in pericytes, which in turn leads to degradation of the basement membrane and TJ proteins, causing chronic BBB breakdown followed by neuronal dysfunction and secondary neurodegenerative changes . In contrast, apoE3 and apoE2, which confer a lower risk for AD, suppress the CypA-MMP-9 pathway through LRP1 on pericytes, supporting the maintenance of BBB functions (Figure 3) . On the other hand, pericyte loss leads to the loss of astrocyte-derived components from the endfeet (Armulik et al., 2010) , but the pericyte-derived signal(s) in this case are unknown. Astrocytes Astrocytes contribute to a variety of dynamic regulations in the neural system and play a vital role in CNS inflammation in neurodegenerative diseases (Clarke and Barres, 2013; Sofroniew, 2015) . However, it remains unclear whether astrocytes Endothelial cells are connected with each other through the tight junction (TJ), adherens junction (AJ) and gap junction (GJ) proteins. In the TJs, occludin, claudins and junctional adhesion molecules (JAMs) form a impermeable barrier to fluids and are connected to F-actin filaments by the zonula occludens ZO-1, ZO-2 and ZO-3 multi-domain scaffolding proteins of the membrane-associated guanylate kinase family. GJs formed by connexin hemichannels are specialized for direct intercellular communications. AJs are formed by homotypic binding of VE-cadherin, platelet endothelial cell adhesion molecule-1 (PECAM-1) and Nectin. Catenins link VE-cadherin to F-actin, while nectin is secured to F-actin by afadin. Pericytes communicate with the endothelial cells via growth factor-mediated signaling (unidirectional or bidirectional), adhesion via N-cadherin homotypic binding and GJs. Pericyte can modulate BBB permeability by regulating gene expression in the endothelial cells resulting in upregulation of TJ proteins, inhibition of bulk flow transcytosis and upregulation of brain endothelial specific docosahexaenoic acid (DHA) transporter, a major facilitator domain-containing protein 2A (MFSD2a). Both endothelial cells and pericytes are embedded in the basement membrane (BM) and anchored to BM via integrins. PDGF-BB, platelet-derived growth factor BB; PDGFRb, platelet-derived growth factor receptor-b. Astrocytes regulate expression of matrix metallo-proteinase-9 (MMP-9) in pericytes by secreting apolipoprotein E (ApoE). ApoE3, but not ApoE4, binds to the low density lipoprotein receptor-related protein 1 (LRP1) in pericytes, which suppresses the proinflammatory cyclophilin A (CypA) nuclear factor kB (NFkB) MMP-9 pathway and degradation of TJ and BM proteins causing BBB breakdown. Astrocytes signal endothelial cells by Src-suppressed C-kinase substrate (SSeCKS) to increase TJ protein expression. Neural activity-dependent glutamate release increases [Ca 2+ ] in the astrocytic endfeet, which regulates vascular tone. The GJs connect the adjacent astrocytic endfeet. Glucose gets into the brain via the endothelial Glut1 transporter and is taken up by neurons via Glut3. Glucose is taken up by astrocytes mainly by Glut2 and is metabolized to lactate, which is exported to neurons by the monocarboxylic MCT1 and MCT4 transporters.
are essential for BBB maintenance. The glial limitans ensheathing the penetrating arterial blood vessels and the outer layer of mature capillaries are formed by astrocytic endfeet (Figure 3 ). Yet, genetic lineage tracing and ablation studies showed that regional ablation had no effect on BBB permeability (Tsai et al., 2012) . In contrast, others have shown that Src-suppressed C-kinase substrate (SSeCKS) in astrocyte progenitors regulates angiogenesis and formation of TJs at the BBB by modulating VEGF and Ang-1 expression (Lee et al., 2003) . Future studies should provide more definitive answers as to whether astrocytes play a role in BBB maintenance in the adult and aging brain.
BBB and Monogenic Neurological Disorders
Several genetic diseases appear to originate in individual cell types of the NVU and link to specific roles in BBB development, function, and regulation. Such diseases, while rare, offer insights into causal pathogenic links and chains of events. Below, we briefly discuss some of these diseases, the relevant cell types (Table 2) , and the potential pathogenic role of BBB dysfunction. Endothelial Cells Several inherited CNS diseases are caused by mutations in genes that play pivotal roles in endothelial cells or in the endothelium-derived ECM. These genes encode proteins that are either structural components or regulators of the endothelial cell-cell junctions, the vascular basement membrane, or transporters critically involved in BBB maintenance. For instance, mutations in the genes encoding the TJ proteins occludin (O'Driscoll et al., 2010) and junctional adhesion molecule C (JAM-C) (Woodfin et al., 2011) lead to severe problems in brain growth, hemorrhage, and calcification (Table 2 ). These pathologies may result from uncontrolled leakage of solutes and plasma proteins across the endothelial junctions and/or neuroinflammatory changes due to increased trans-endothelial migration of leukocytes, a process inhibited by JAM-C. Another example is familial cerebral cavernous malformations (CCM), occurring in hereditary or sporadic forms and together affecting 0.5% of the population. CCM is caused by mutations in three genes, CCM1-3, leading to similar thin-walled, leaky vascular lesions of venous origin (Fischer et al., 2013) . The CCM proteins likely act together in a complex that maintains endothelial junctional organization and polarization and inhibits endothelial-to-mesenchymal transition (Maddaluno et al., 2013) . Collagen COL4A1 and COL4A2 are abundant in all basement membranes and are expressed by many cell types, including vascular endothelial cells. Mutations in these genes are associated with a diverse range of problems in several organs, including the brain, where they are associated with cerebral hemorrhage and small vessel disease (Gould et al., 2006) . Work in animal models with Col4a1 deficiency suggests that increased vessel fragility could make the animal susceptible to hemorrhage either upon mild trauma or due to the anatomy of the vessel that is particularly sensitive to increased hemodynamic stress (Kuo et al., 2012) .
Among transporters mutated in brain disorders, two striking examples of BBB endothelial proteins are GLUT1 and MFSD2a. GLUT1, the major glucose transporter at the BBB, is mutated and functionally inactivated in human GLUT1 deficiency syndrome, a disease associated with early-onset seizures and microcephaly (Wang et al., 2000) . This is consistent with the importance of sufficient GLUT1 levels and glucose transport across the BBB for brain function and its role in maintaining the BBB integrity . Similar to GLUT1, MFSD2a is highly expressed on brain endothelial cells. It transports lipids in the form of lysophoshatidylcholine coupled to certain long fatty acyl chains and is critical for the maintenance of the BBB integrity (Ben-Zvi et al., 2014; Nguyen et al., 2014) . Microcephaly syndrome was recently shown to be caused by inactivating mutations in MFSD2A, the severity of the syndrome correlating with the degree of functional inactivation of the MFSD2A protein (Alakbarzade et al., 2015; Guemez-Gamboa et al., 2015) . These studies provide insight into the cause of a rare disease but, perhaps more importantly, are an illustration to how basic physiological knowledge may come from human and mouse genetics and offer a fundamental insight into the mechanisms by which brain transports lipids across the BBB (Betsholtz, 2015) and maintains BBB integrity (Betsholtz, 2014; Zhao and Zlokovic, 2014) . A third example of a brain disease associated with a BBB transporter is Allan-Herndon-Dudley syndrome, a psychomotor retardation syndrome caused by inactivating mutations in the triiodothyronin (T3) transporter SLC16A2 (MCT8) (Dumitrescu et al., 2004; Friesema et al., 2004) . It is thought that the severe intellectual disability and movement problems observed in these patients are due to deficient transport of T3 from the blood to the brain, resulting in impairment of neuronal development and function. Indeed, different degrees of SLC16A2 inactivation correlate with the phenotypic consequences in patients (Capri et al., 2013) . Vascular Mural Cells CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is a relatively common (2-4/100,000 individuals) autosomal-dominant stroke syndrome caused by mutations in NOTCH3, a gene known to be specifically expressed in vascular mural cells (Chabriat et al., 2009) . Although, the precise pathogenic mechanisms of CADASIL remain unresolved, recent studies of Notch 3 null mice demonstrated focal disruption of the BBB with tracer leakage and perivascular fibrin deposits in the CNS (Henshall et al., 2015) . Primary familial brain calcification (PFBC, a.k.a., idiopathic basal ganglia calcification [IBGC] or Fahr's disease) is characterized by early-onset microvascular calcification occurring in certain deep brain regions, most notably the basal ganglia. Disease symptoms include motoric and cognitive problems suggestive of significant neuronal dysfunction. The recent description of loss-of-function mutations in PDGFB and PDGFRB genes in PFBC (Keller et al., 2013; Nicolas et al., 2013) suggests a role for pericytes in this disease. In different mouse models based on mutations in Pdgfb that led to variable levels of defect in PDGF-B/PDGFRb signaling, a correlation was noted among the extent of pericyte loss, BBB deficiency, and brain calcification (Keller et al., 2013) . This is suggestive of a role for BBB dysfunction in PFBC, possibly involving changes in phosphate transport, since mutations in the phosphate transporters SLC20A2 and XPR1 also cause PFBC (Legati et al., 2015; Wang et al., 2012a) . Astrocytes and Microglia Mutations in astrocyte-specific genes are associated with various neurological disorders, such as glial fibrillay acidic protein (GFAP) in Alexander disease and MLC1 and HEPACAM in megalecenphalic leukoencephalopathy with subcortical cysts. These mutations may affect BBB integrity. However, the involvement of brain vascular dysfunction in these diseases remains to be established. Laminin a2 chains (LAMA2), an astrocyte gene encoding the basement membrane protein LAMA2, is mutated in congenital muscular dystrophy, a disease that affects the brain in some patients in ways that are suggestive of a defective BBB (e.g., brain edema) (Alkan et al., 2007) . Reactive microglia are commonly found in association with leaky brain vessels. Mutations in the microglia-specific genes DAP12 and TREM2 cause Nasu-Hakkola disease (Sasaki et al., 2015) , a neurodegenerative disorder with unclear pathogenesis. It remains to be determined whether Nasu-Hakkola disease is associated with a dysfunctional BBB. ), causing production of reactive oxygen species (ROS) and oxidant stress to neurons; (2) neuronal toxic blood-derived proteins such as fibrinogen, thrombin, and plasminogen, which could be converted into plasmin that, in turn, degrades neuronal extracellular matrix (ECM) and leads to detachment of neurons and cell death; (3) fibrinogen that activates microglia, promotes neuroinflammation and demyelination, and prevents myelination by oligodendrocyte progenitor cells; (4) albumin that contributes to the development of vasogenic edema, capillary hypoperfusion, and hypoxia. BBB breakdown can also lead to the loss of immune privilege, resulting in development of anti-brain antibodies against different axonal and membrane components of neurons.
BBB and Multifactorial Neurodegenerative Diseases
2015; Sweeney et al., 2015) and other neurodegenerative disorders, such as ALS , PD (Korczyn, 2015) , and Huntington disease (HD) (Drouin-Ouellet et al., 2015) , are increasingly recognized. A number of vascular dysfunctions are frequently associated with neurodegeneration, including hypertension, cerebrovascular disorder, BBB breakdown, etc. (Iadecola, 2013; Montagne et al., 2015; Snyder et al., 2015) . Experimental studies in murine transgenic models with a chronic BBB breakdown due to aberrant endothelial-pericyte and/or astrocyte-pericyte signaling have shown that accumulation in the CNS, particularly in neurons, of blood-derived neurotoxic proteins, including fibrinogen, thrombin, red-blood-cell-derived hemoglobin, iron-containing hemosiderin, free iron, and/or plasmin, can initiate and/or contribute to neurodegeneration (Armulik et al., 2010; Bell et al., 2010 Bell et al., , 2012 Daneman et al., 2010; Davalos et al., 2012) . ApoE knockout mice with dysfunctional BBB, but not wild-type mice with normal BBB, develop psychotic behavioral impairment when injected with N-methyl-D-aspartate receptor autoantibody-positive serum, suggesting that seroprevalence in neuropsychiatric diseases could be related to an insult to BBB integrity (Hammer et al., 2014) . The model that we propose in Figure 4 may apply to various types of vascular-mediated neurodegeneration.
Accumulations of blood-derived proteins in the hippocampus and cortex (e.g., immunoglobulins, albumin, fibrinogen, and thrombin) were observed in post-mortem human studies, indicating BBB damage in AD Hultman et al., 2013; Sweeney et al., 2015; Zipser et al., 2007) and ALS , both associated with degeneration of pericytes (Baloyannis and Baloyannis, 2012; Farkas and Luiten, 2001; Halliday et al., 2015; Sengillo et al., 2013; Winkler et al., 2013) . BBB impairments were also found in other neurological disorders, including multiple sclerosis, PD, and HD (DrouinOuellet et al., 2015; Korczyn, 2015; Zlokovic, 2011) . Moreover, microbleeds and accumulation of iron were observed in the brains of patients with preclinical and clinical AD symptoms (Yates et al., 2014; Zonneveld et al., 2014) , particularly in the hippocampus (Raven et al., 2013) . It has also been shown that age-dependent early BBB breakdown is accelerated in individuals with mild dementia (Montagne et al., 2015) . Some studies using the CSF-to-plasma ratio of blood-derived albumin also reported BBB damage in AD particularly associated with vascular risk factors or in individuals at a genetic risk for AD . Thus, findings in complex human brain diseases support, at least in part, the proposed model of vascular-mediated neurodegeneration (Figure 4) . Below, we discuss AD in greater detail.
AD patients develop an early neurovascular dysfunction, progressive neurodegeneration, selective loss of neurons, and accumulation in the brain of Ab pathology and neurofibrillary tangles composed of aggregated hyperphosphorylated Tau (Querfurth and LaFerla, 2010; Zlokovic, 2011) . Strikingly, AD affects all cell types of the NVU depending on the disease stage, including endothelial and mural cells, glia, and neurons . The neurovascular hypothesis of AD proposes that cerebrovascular dysfunction and disruption in the neurovascular integrity contribute to the onset and progression of cognitive decline and that cerebral blood vessels are the converging point Figure 5 . The Neurovascular Hypothesis for Alzheimer's Disease AD genetics, vascular factors, environment, and lifestyle can independently and/or synergistically lead to cerebrovascular injuries, including BBB dysfunction, pericyte degeneration, and cerebral blood flow reductions (oligemia), initiating a cascade of events that can either: (1) directly cause neuronal injury and damage independently of Ab (hit 1, blue) and/or (2) accelerate the Ab-dependent neurodegeneration (hit 2, red). In the Ab-dependent pathway, BBB dysfunction leads to faulty clearance of Ab from brain, whereas reduced brain perfusion increases Ab production, both causing Ab accumulation in the brain. Reduced brain perfusion (Hit 1) and elevated levels of Ab (Hit 2) can independently and/or synergistically lead to Tau hyperphosphorylation (p-Tau) and formation of filamentous Tau pathology. Additionally, the two hits can exacerbate neuroinflammation.
of pathogenic events leading to dementia (Zlokovic, 2011) . Vascular damage can be triggered by genetics, vascular risk factors, environmental factors, and lifestyle Sweeney et al., 2015; Zlokovic, 2011) . Primary damage of the cerebrovasculature leads to brain accumulation of blood-derived neurotoxins, and the decrease in brain perfusion can cause neuronal injury. Vascular damage also influences neurodegeneration pathway mediated by Ab. In combination, vascular damage and elevated Ab have a striking synergistic effect on neuronal Tau phosphorylation and pathology, leading to accelerated loss of neurons (Figure 5 ).
Faulty Ab clearance from the brain leads to elevated Ab in patients with sporadic AD (Mawuenyega et al., 2010) . Experimental studies have shown that, in various animal models, Ab is cleared from the brain primarily by trans-vascular clearance across the BBB (70%-85%), whereas a minor portion is removed by the ISF flow (Bading et al., 2002; Deane et al., 2004; Tarasoff-Conway et al., 2015) . The molecular mechanism for Ab clearance across the BBB has been recently elucidated in greater detail (Figure 6 ). In brief, Ab produced in the brain binds to LRP1 at the abluminal side of the BBB, causing its rapid internalization into endothelial cells and clearance through the blood. Phosphatidylinositol-binding clathrin assembly protein (PICALM) is critical for clathrin/PICALM-mediated internalization of LRP1-Ab complexes by the endothelium and guides intracellular trafficking of Ab-containing endocytic vesicles across endothelium by sequential fusion with Rab5-positive early endosomes and Rab11-positive sorting endosomes for exocytosis at the luminal side of the BBB, which completes Ab transcytosis cycle across the BBB .
In plasma, the soluble form of LRP1 (sLRP1) generated by the proteolytic cleavage of LRP1 by b-secretase binds and sequesters free Ab40 and Ab42 , mediating Ab transport via blood to the excretory organs (Figure 6 ). Ab42 can bind to Clusterin (CLU or apoJ) in the brain ISF, and apoJ-Ab complexes are transported across the BBB into circulation by LRP2 . Enzymatic degradation of Ab by neprilysin, insulin-degrading enzyme, matrix metalloproteinases, plasmin, and tissue plasminogen activator contributes to its clearance from brain (Querfurth and LaFerla, 2010) .
Several frequently studied genes, of which the mutations are associated with high risk for sporadic and familial AD, play a role in the cerebrovascular system. For instance, APOE4 is the strongest genetic risk factor for late-onset AD that exerts direct toxic cerebrovascular effects (Zlokovic, 2013) . Compared to the other two APOE isoforms, i.e., APOE3 or APOE2, APOE4 increases BBB damage, cerebral amyloid angiopathy, and fibrinogen and iron deposition in the brain of AD patients (Halliday et al., 2013 Hultman et al., 2013; Sweeney et al., 2015; Zipser et al., 2007; Zonneveld et al., 2014) . Consistently, findings in APOE4 transgenic mice suggest that vascular changes may precede neuronal changes and behavioral deficits . ApoE can bind to Ab. While ApoE2-Ab and ApoE3-Ab complexes are rapidly cleared across the BBB via LRP1, the removal rate of ApoE4-Ab complexes is lower, mediated by slow internalization and transcytosis via very low-density lipo- protein receptor (VLDLR) Deane et al., 2008) (Figure 6 ).
Another example is PICALM, a validated genetic risk factor for AD (Harold et al., 2009; Lambert et al., 2009) . PIC-ALM mediates endocytosis and internalization of cell receptors and intracellular trafficking of endocytic proteins (Treusch et al., 2011; Zhao et al., 2015) . It is highly expressed in brain endothelium of the BBB (Parikh et al., 2014; Zhao et al., 2015) and plays a central role in Ab clearance across the BBB (Figure 6 ). A recent study suggested that, compared to the protective allele, the non-protective allele of the rs3851179 PICALM variant leads to decreased PICALM expression in endothelial cells and substantially lower Ab clearance in an in vitro model of the BBB , suggesting that PICALM variants may affect AD pathogenesis, potentially through a vascular mechanism.
Similarly, mutations in Clusterin (CLU, apoJ) are associated with sporadic AD (Harold et al., 2009; Lambert et al., 2009) . CLU binds to several different proteins, including Ab, and has been shown to prevent aggregation and promote clearance of Ab peptides across the BBB (Figure 6 ). Presenilin (PSEN) mutations cause autosomal-dominant AD and increase Ab production in the brain (Querfurth and LaFerla, 2010) . PSEN1 mutations also lead to major cerebrovascular pathology in humans, including degeneration of pericytes and mural cells, BBB breakdown, and Ab deposits in small cerebral vessels . Similar cerebrovascular pathology was found in transgenic PSEN1 mice (Gama Sosa et al., 2010) , although it is worth noting that how vascular pathology relates to the increased Ab production during disease progression remains elusive.
Conclusions and Future Directions
Recent advances in human genetics and the corresponding transgenic models indicate that almost every non-neuronal cell type of the NVU could be affected by some monogenic inherited disorders. This association can provide insights into the potential pathogenic links among BBB dysfunction, neuronal injury, neurodegeneration, and neurological disorders caused by NVU disruption and BBB breakdown. On the other hand, the relationship among neurovascular integrity, brain structural and functional connectivity, cognitive function, and neurological symptomatology in complex disorders such as AD still awaits to be directly explored in the most relevant in vivo context, which has only recently became possible with the development of novel state-of-the art neuroimaging and molecular biomarker approaches. Experimental studies combining genetic, environmental, and lifestyle factors hold promise to further advance our knowledge of multifactorial CNS disorders and to establish the concept that the loss of healthy cerebral blood vessels and BBB integrity influences the course and clinical phenotype of neurological disorders in a region-specific manner.
Some important questions remain to be addressed. First, it is still unclear whether in the living human brain, cerebrovascular changes and BBB breakdown can drive the initial pathogenic events that lead to neuronal injury, disrupted structural and functional brain connectivity, and early neurological symptoms, such as cognitive decline in AD and motor changes in ALS, PD, or HD. Second, further studies are warranted to test whether the underlying molecular mechanisms of NVU disruption and BBB breakdown might point to new targets for therapeutic development to prevent and/or treat neurodegenerative disorders. Third, technological advance is required to determine whether neurovascular dysfunction and BBB breakdown are detectable in the living human brain prior to the development of the full spectrum of neurological symptoms. Last but not least, future investigations need to address whether molecular and imaging biomarkers of neurovascular dysfunction can serve as reliable prognostic and/or diagnostic tools to predict the development of neurodegenerative disorders.
From the basic science side, pushing the envelope further to generate a comprehensive proteomics and RNA-seq molecular atlas of the BBB in animals and humans would provide a valuable resource for discovering and studying new targets and signaling pathways mediating the crosstalk among different cell types within the NVU. This may lead to the development of new transgenic animal models-pluripotent stem cell models of the BBB, NVU, and different neurological disorders-serving as valuable platforms for drug discovery and for testing novel drug delivery approaches.
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